Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells

2 Sept 2015

Abstract excerpt

Epoxyboetirane A (1), a macrocyclic diterpene that was found to be inactive as an ABCB1 modulator, was submitted to several chemical transformations, aimed at generating a series of compounds with improved multidrug resistance (MDR)-modifying activity. Overall, 23 new derivatives were prepared, in addition to the already reported epoxylathyrol (2) and methoxyboetirol (3). Their anti-MDR potential was assessed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Drug Transport and Resistance Mechanisms
Share to Natural Compounds in Disease Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26331763
DOI: 10.1021/acs.jnatprod.5b00370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma CellsPMID 26331763Read ↗

Macrocyclic diterpenes resensitizing multidrug resistant phenotypes.Semantic proximity Read ↗

Epoxycarotenoids and Cancer. ReviewSemantic proximity Read ↗

Synthesis of α,β-Unsaturated Carbonyl-Based Compounds, Oxime and Oxime Ether Analogs as Potential Anticancer Agents for Overcoming Cancer Multidrug Resistance by Modulation of Efflux Pumps in Tumor Cells.Semantic proximity Read ↗

Investigational ABC transporter inhibitorsSemantic proximity Read ↗

Enaminones: Exploring additional therapeutic activities.Semantic proximity Read ↗

Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in CancerSemantic proximity Read ↗

Lupane derivatives containing various aryl substituents in the position 3 have selective cytostatic effect in leukemic cancer cells including resistant phenotypes.Semantic proximity Read ↗

Chemical Duality of Verbesina Metabolites: Sesquiterpene Lactones, Selectivity Index (SI), and Translational Feasibility for Anti-Resistance Drug DiscoverySemantic proximity Read ↗

Epetraborole Is Active against Mycobacterium abscessusSemantic proximity Read ↗

Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.Semantic proximity Read ↗

Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.Semantic proximity Read ↗

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer ChemotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.